Purchase Order W81K0222P0104
Award Date 10/1/22
Potential Completion Date 9/30/27
Potential Value $4.3M
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Castleton, IN 46256, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
5
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Health Agency awarded a purchase order to Roche Diagnostics Corporation for two chemistry analyzers including clinical chemistry and immunodiagnostic reagents and calibrator, valued at $1,588,276.31, effective July 1, 2021. Performance is at Castleton, Indiana. The order is firm fixed price with no set-aside designation. Ultimate completion was September 30, 2025. The acquisition originated from an Army Medical Command cost-per-test lease solicitation posted March 1, 2021, for Bach...
- <p>The Defense Health Agency issued a delivery order to Roche Diagnostics Corporation on April 1, 2023, with a ceiling value of $679,161.02 for chemistry analyzer equipment and chemical reagents, with an ultimate completion date of March 31, 2028.</p> <p>The order is issued under the GSA Schedule Critical Analyzers, Laboratory (FSS-66-III). Place of performance is Fort Drum, NY. The order is priced on a firm fixed-price basis with no set-aside designation.</p>
- The Defense Health Agency awarded a purchase order to Werfen USA LLC for immunohematology reagents and supplies with use of an Echo Lumena analyzer for the Department of Pathology at Tripler Army Medical Center, Hawaii, with a ceiling value of $1,762,064.31, effective October 1, 2022. The order covers a base period from October 1, 2022 through September 30, 2023, with ultimate completion dated September 30, 2027. Place of performance is Peachtree Corners, Georgia. The procurement covers blood...
- Roche Diagnostics Corporation received a $3.62 million delivery order from the Defense Health Agency on December 1, 2022, for clinical chemistry and immunoassay analyzers with performance extending through September 30, 2027. This firm fixed-price contract, awarded without set-aside designation, represents a child order under the GSA Schedule Critical Analyzers, Laboratory (FSS-66-III) and leverages Roche's established relationship with the Defense Health Agency for diagnostic laboratory...
- <p>The Defense Health Agency issued a delivery order to Roche Diagnostics Corporation on October 1, 2025, with a ceiling value of $2,212,608.85 for chemistry and immunoassay testing services.</p> <p>Place of performance is Fort Sam Houston, TX (2330 Stanley Rd). The order expires September 30, 2026. The scope covers chemistry and immunoassay testing as detailed in the statement of work. Pricing is firm fixed price, and no set-aside was used.</p>
- <p>The Defense Health Agency issued a delivery order to Roche Diagnostics Corporation on October 1, 2025, with a ceiling value of $1,947,947.79 for reagents, supplies, training, and maintenance supporting a government-owned Roche Diagnostic Total Laboratory Automation System. The order is firm fixed price with no set-aside and ultimate completion by September 30, 2026. Place of performance is Lewis-McChord, WA.</p>
- The Defense Health Agency awarded a $24,547.20 firm fixed-price call order to Roche Diagnostics Corporation for blood testing reagents required to perform medical laboratory testing. The award, issued on December 19, 2025, is scheduled for completion by September 30, 2026, and represents a child contract under a larger blanket purchase agreement vehicle. The work will be performed at Roche's facility in Castleton, Indiana. No set-aside designation was applied to this procurement, indicating open...
- <p>The Defense Health Agency issued a $1.685 million delivery order to Roche Diagnostics Corporation on October 1, 2026, for an automated core lab under a firm fixed-price arrangement with a completion date of September 30, 2027.</p> <p>Place of performance is Castleton, Indiana. The order carries no set-aside designation and procures in vitro diagnostic laboratory equipment, reagents, and associated medical products for federal healthcare operations.</p>
- The Defense Health Agency issued a BPA call to Roche Diagnostics Corporation with a ceiling value of $182,375.48 on October 1, 2025, for chemistry analyzer and reagents priced on a cost-per-reportable-result basis, with ultimate completion by January 31, 2026. The call is placed against the Defense Health Agency's existing BPA with Roche for chemistry analyzers and reagents, which carries a total contract value of $606,000 through March 2027. Work is performed in Castleton, Indiana. The...
- The Defense Health Agency awarded a delivery order valued at $482,006 to Roche Diagnostics Corporation for chemistry and immunoassay laboratory testing services on a cost-per-reportable-result basis. This non-set-aside contract, effective May 1, 2022, through April 1, 2023, will be performed at Roche's facility in Castleton, Indiana. The award utilizes firm fixed-price pricing under the Critical Analyzers, Laboratory (FSS-66-III) General Services Administration schedule, enabling the federal...